Enterprise Value
194.7M
Cash
118.5M
Avg Qtr Burn
-14.37M
Short % of Float
13.07%
Insider Ownership
4.96%
Institutional Own.
88.41%
Qtr Updated
03/31/24
Drug Pipeline
Powered by
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
| Drug & Indication | Stage & Event | Catalyst Date |
|---|